Axonics gets FDA nod for fourth-generation rechargeable neurostimulator

By NS Medical Staff Writer

01 Feb 23

The new-generation neurostimulator, dubbed Axonics R20, requires to be recharged only once every six to 10 months for…

DevicesNeurological

Abbott wins FDA approval for Proclaim XR SCS system to treat painful DPN

By NS Medical Staff Writer

27 Jan 23

Abbott’s Proclaim XR SCS system was previously approved in the US, in 2019, for the treatment of chronic…

DevicesNeurological

Brain Scientific Partners with SysteMedic, Receives First Purchase Order for NeuroCaps in Israel

By NS Medical Staff Writer

27 Jan 23

International Markets Show Immediate and Increasing Demand for FDA-Cleared, CE Mark-Approved NeuroCap Device

DevicesNeurological

Avail Scientific to acquire neurological testing firm Relai Neuro

By NS Medical Staff Writer

20 Jan 23

Avail is a biopharmaceutical company focused on therapies for addiction, and substance abuse, and is also creating a…

DevicesNeurological

Novarad’s VisAR System demonstrates high accuracy for EVD placement

By NS Medical Staff Writer

19 Jan 23

VisAR is FDA cleared for stereotactic spine guidance and under review for cranial procedures

DevicesNeurological

electroCore, Inc. Launches New Wellness Product Offering for Stress, Anxiety and Sleep, Truvaga

By NS Medical Staff Writer

21 Dec 22

Truvaga is a handheld non-invasive vagus nerve stimulator that utilizes our proven technology to quickly and gently activate…

DevicesNeurological

US FDA approves Abbott’s Eterna SCS system to treat chronic pain

By NS Medical Staff Writer

20 Dec 22

The Eterna SCS system leverages the company’s low-dose BurstDR stimulation that mimics natural firing patterns around the brain…

DevicesNeurological

Sonorous NV Uses New Device to Treat Patients with Symptomatic Cerebral Venous Diseases

By NS Medical Staff Writer

19 Dec 22

he single-use, implantable device acts as an endoluminal prothesis that is placed into a cerebral venous sinus stenosis…

DevicesNeurological

Synchron secures $75m financing to advance endovascular BCI product

By NS Medical Staff Writer

16 Dec 22

The endovascular brain-computer interface (BCI) company will use the funding to support the development of its BCI product,…

DevicesNeurological

ClearPoint recruits first patient in Glioblastoma study of its laser therapy system

By NS Medical Staff Writer

13 Dec 22

The study, dubbed Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions, is a single-arm clinical…

DevicesNeurological